National Institute on Drug Abuse; Notice of Closed Meetings, 89463 [2023-28574]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 247 / Wednesday, December 27, 2023 / Notices
Dated: December 20, 2023.
Surekha Vathyam,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2023–28474 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; JCOIN
Methodology Center (MAARC) and JCOIN
Coordination Center (CTC).
Date: February 16, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC, 6021
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Research Center of Excellence Grant Program
and NIDA Core ‘‘Center of Excellence’’ Grant
Program.
Date: February 26–27, 2024.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC, 6021
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
VerDate Sep<11>2014
19:00 Dec 26, 2023
Jkt 262001
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Research at Minority Serving Institutions on
Neurocognitive Mechanisms Underlying the
Impact of Structural Racism on the Substance
Use Trajectory.
Date: March 14, 2024.
Time: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Shareen Amina Iqbal,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 443–4577,
shareen.iqbal@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: December 21, 2023.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28574 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Advisory Child Health and
Human Development Council Stillbirth
Working Group Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Eunice Kennedy Shriver
National Institute of Child Health and
Human Development (NICHD) Stillbirth
Working Group of Council is charged
with identifying current knowledge on
stillbirth and prevention, areas of
improvement for data collection, current
resources for families impacted by
stillbirth, and next steps to gather data
and lower the rate of stillbirth in the
United States.
DATES: The Virtual Meeting will be held
on January 24, 2024, from 9 a.m. to 3:30
p.m. EST.
ADDRESSES: The meeting will be open to
the public. Individuals who need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The session will be
Frm 00102
Fmt 4703
videocast and can be accessed from the
NIH Videocasting website (https://
videocast.nih.gov/).
FOR FURTHER INFORMATION CONTACT: For
information concerning this meeting,
Dr. Natasha H. Williams, Branch Chief,
Office of Legislation and Public Policy
NICHD, NIH, 6710B Rockledge Drive,
Bethesda, MD 20892–7510,
natasha.williams2@nih.gov, (240) 551–
4985.
This
notice is pursuant to 42 U.S.C. 285g.
Any interested person may file written
comments with the committee by
forwarding the statement to the Contact
Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory,
where an agenda and any additional
information for the meeting will be
posted when available.
SUPPLEMENTARY INFORMATION:
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver
National Institute of Child Health and Human
Development, National Institutes of Health.
[FR Doc. 2023–28444 Filed 12–26–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
SUMMARY:
PO 00000
89463
Sfmt 4703
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 88, Number 247 (Wednesday, December 27, 2023)]
[Notices]
[Page 89463]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28574]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; JCOIN Methodology Center (MAARC) and JCOIN
Coordination Center (CTC).
Date: February 16, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 594-9460, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Research Center of Excellence Grant Program and
NIDA Core ``Center of Excellence'' Grant Program.
Date: February 26-27, 2024.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 594-9460, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Research at Minority Serving Institutions on
Neurocognitive Mechanisms Underlying the Impact of Structural Racism
on the Substance Use Trajectory.
Date: March 14, 2024.
Time: 1:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Shareen Amina Iqbal, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC, 6021 Bethesda, MD 20892, (301) 443-4577, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: December 21, 2023.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28574 Filed 12-26-23; 8:45 am]
BILLING CODE 4140-01-P
